A microRNA-operated switch of asymmetric-to-symmetric cancer stem cell divisions

Robin G Lerner1, Claudia Petritsch1

  • 1Department of Neurological Surgery, Brain Tumor Research Center, Helen Diller Comprehensive Cancer Center, Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, California, USA.

Nature Cell Biology
|March 1, 2014
PubMed

Insights

Defects in stem cell division contribute to cancer. A new study reveals the Snail, microRNA-146a, and Numb signaling pathway controls cell division symmetry in colorectal cancer stem cells.

Area of Science:

  • Stem cell biology
  • Cancer research
  • Molecular signaling

Background:

  • Asymmetric cell division is crucial for stem cell maintenance and tissue homeostasis.
  • Defects in cell division, particularly asymmetric divisions, are implicated in tumorigenesis.
  • The precise molecular mechanisms regulating cell division symmetry in cancer stem cells remain largely undefined.

Purpose of the Study:

  • To elucidate the molecular mechanisms governing the switch between symmetric and asymmetric cell division in colorectal cancer stem cells.
  • To identify key signaling pathways involved in regulating cell division asymmetry in the context of cancer.

Main Methods:

  • Investigated the roles of Snail, microRNA-146a, and Numb in colorectal cancer stem cells.
  • Utilized molecular biology techniques to analyze the signaling axis.
  • Examined the regulation of cell division symmetry.

Main Results:

  • Identified a novel signaling axis comprising Snail, microRNA-146a, and Numb.
  • Demonstrated that this axis regulates the balance between symmetric and asymmetric cell division.
  • Showed the critical role of this pathway in colorectal cancer stem cells.

Conclusions:

  • The Snail/microRNA-146a/Numb signaling axis is a key regulator of cell division symmetry in colorectal cancer stem cells.
  • Understanding this mechanism provides insights into how stem cell division defects contribute to cancer development.
  • This pathway represents a potential therapeutic target for colorectal cancer treatment.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K